ESC Professional Premium Access

Clinician perceptions and reasons for non-use of guideline-directed medical therapy for heart failure with reduced ejection fraction in the United States

Congress Presentation

About the speaker

Doctor Stephen Greene

Duke Clinical Research Institute, Durham (United States of America)
9 presentations
1 follower

7 more presentations in this session

Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure

Speaker: Doctor Y. Nishihara (Kobe, JP)


Real world data on adopting guideline directed medical therapy post 2021 ESC HF guidelines and effect on renal function.

Speaker: Mr M. Ferrari (Brescia, IT)


Use of guideline-recommended heart failure drugs in high-, middle- and low-income countries: a systematic review and meta-analysis

Speaker: Associate Professor S. Peters (Utrecht, NL)


Candidacy and predicted efficacy of vericiguat in contemporary heart failure outpatient clinics

Speaker: Doctor B. Soh (Waterford, IE)


Quadruple therapy for heart failure before and after electronic cardiac device implantation - are we hitting our targets?

Speaker: Doctor F. Rode (Zagreb, HR)


Access the full session

Pharmacotherapy in heart failure

Speakers: Doctor S. Greene, Doctor Y. Nishihara, Mr M. Ferrari, Associate Professor S. Peters, Doctor B. Soh...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb